31/7/19

Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients

Nicolè S, Lanzafame M, Lattuada E, Luise D, Vecchi M, Tacconelli E, Vento S.

Infect Dis (Lond). 2019 Aug;51(8):615-617. doi: 10.1080/23744235.2019.1609078. Epub 2019 May 12.

Not available